Cite

    Fukuhara, T., Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., Fujita, Y., Saijo, Y., Hagiwara, K., Morita, S., & Nukiwa, T. (n.d.). factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation. Lung cancer, 88(2), 181–186. http://access.bl.uk/ark:/81055/vdc_100026006486.0x00000d